The IL-2 receptor (IL-2R) is a heterotrimeric protein that binds to IL-2 and reacts to it on the surface of some immune cells, like lymphocytes. IL-2R is made up of three subunits: IL-2Rα (CD25 ...
Medpage Today on MSN6mon
IL-2 Receptor-Targeted Therapy Approved for Relapsed/Refractory CTCLA novel immunotherapeutic agent, denileukin diftitox targets the interleukin (IL)-2 receptor on malignant T cells and T ...
The Swiss pharma group has agreed to buy Seattle-based biotech Good Therapeutics and its preclinical-stage PD-1-regulated IL-2 receptor agonist programme for $250 million upfront, with undisclosed ...
Recent research has focused on the role of the IL-2 receptor in acute allograft rejection. T-cell proliferation, a central event leading to graft rejection, is triggered by the interaction of IL-2 ...
leading to a decrease in IL-2 and IL-2 receptor gene expression. The lack of IL-2 or its functional receptor blocks the generation of Tregs both in the thymus and in the periphery. [123] CsA has ...
Denileukin diftitox (Ontak ®; Esai, Inc., Woodcliff Lake, NJ) is a chimeric immunotoxin composed of the modified cytotoxic domain of diphtheria toxin and human interleukin-2 (IL-2) protein. 1 The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback